PERSPECTA

News from every angle

← Back to headlines

Imunon to Host Ovarian Cancer R&D Day on September 23

Oncology-focused biopharmaceutical company Imunon will present updates on its experimental ovarian cancer therapies during a dedicated research and development event.

26 Aug, 12:36 — 26 Aug, 12:36
PostShare

Sources

Showing 1 of 1 sources
investing-com3d ago

Imunon to host R&D day on Sept. 23 for ovarian cancer therapy

By Investing.com

Read full article →

Related Stories

Fed Chair Warsh Signals Potential Rate Hikes Amid Stubborn Inflation

1h ago

Temasek Backs Singapore Airlines’ Investment in Air India Amid Scrutiny

1h ago

India Bans Two Major Brands From Selling Hing Powder

1h ago

OpenAI Terminates Partnership With SpaceX-Acquired Cursor Over Contract Dispute

2h ago